Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Copart
CPRT
$31.3B
| $3M | 0.06% |
+98,370
| New | +$2.95M |
|
427
Schrodinger
SDGR
$1.47B
| $2.98M | 0.06% |
159,608
+6,770
| +4% | +$140K |
|
428
Spectrum Brands
SPB
$2B
| $2.98M | 0.06% |
48,960
-18,606
| -28% | -$938K |
|
429
MGP Ingredients
MGPI
$387M
| $2.98M | 0.06% |
28,012
+17,499
| +166% | +$1.96M |
|
|
EVRI
430
DELISTED
Everi Holdings
EVRI
| $2.98M | 0.06% |
207,540
+137,949
| +198% | +$2.29M |
|
|
XAGE
431
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
| $2.98M | 0.06% |
10,000
| – | – |
|
432
Macy's
M
$6B
| $2.96M | 0.06% |
143,606
-142,911
| -50% | -$2.93M |
|
433
CALL
Qualcomm
QCOM
$169B
| $2.96M | 0.06% |
26,900
+13,400
| +99% | +$1.57M |
|
434
Clearway Energy Class C
CWEN
$6.68B
| $2.94M | 0.06% |
+92,419
| New | +$3.11M |
|
435
Cencora
COR
$60.7B
| $2.94M | 0.06% |
+17,762
| New | +$2.81M |
|
436
EXL Service
EXLS
$5.69B
| $2.94M | 0.06% |
+86,680
| New | +$3.01M |
|
437
Dillards
DDS
$9.71B
| $2.92M | 0.06% |
+9,036
| New | +$2.94M |
|
438
Middlesex Water
MSEX
$1.1B
| $2.92M | 0.06% |
37,102
+24,933
| +205% | +$2.16M |
|
439
Bentley Systems
BSY
$11.2B
| $2.92M | 0.06% |
78,934
+32,908
| +71% | +$1.19M |
|
440
Terex
TEX
$7.6B
| $2.92M | 0.06% |
68,269
+32,940
| +93% | +$1.33M |
|
441
CALL
Automatic Data Processing
ADP
$112B
| $2.92M | 0.06% |
12,200
+6,900
| +130% | +$1.69M |
|
|
442
PUT
Qualcomm
QCOM
$169B
| $2.92M | 0.06% |
26,500
+23,300
| +728% | +$2.73M |
|
443
Watsco Inc
WSO
$12.9B
| $2.91M | 0.06% |
+11,683
| New | +$3.07M |
|
444
PUT
Medtronic
MDT
$119B
| $2.91M | 0.06% |
+37,400
| New | +$3.03M |
|
445
LiveRamp
RAMP
$2.28B
| $2.91M | 0.06% |
124,019
+55,458
| +81% | +$1.12M |
|
446
Green Plains
GPRE
$1.14B
| $2.9M | 0.06% |
95,050
+51,642
| +119% | +$1.59M |
|
447
Natera
NTRA
$47.9B
| $2.88M | 0.06% |
71,799
+27,593
| +62% | +$1.14M |
|
448
J.M. Smucker
SJM
$13.3B
| $2.88M | 0.06% |
18,185
+6,872
| +61% | +$1.02M |
|
449
Supernus Pharmaceuticals
SUPN
$2.67B
| $2.88M | 0.06% |
80,707
-11,050
| -12% | -$384K |
|
450
PUT
Analog Devices
ADI
$182B
| $2.85M | 0.06% |
+17,400
| New | +$2.72M |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.